IT1244743B - MEDICATION FOR THE TREATMENT OF DERMATITIS - Google Patents

MEDICATION FOR THE TREATMENT OF DERMATITIS

Info

Publication number
IT1244743B
IT1244743B ITMI910381A ITMI910381A IT1244743B IT 1244743 B IT1244743 B IT 1244743B IT MI910381 A ITMI910381 A IT MI910381A IT MI910381 A ITMI910381 A IT MI910381A IT 1244743 B IT1244743 B IT 1244743B
Authority
IT
Italy
Prior art keywords
treatment
dermatitis
klebsiella
medication
catarrhalis
Prior art date
Application number
ITMI910381A
Other languages
Italian (it)
Inventor
Courten Alfred De
Jean-Claude Farine
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of ITMI910381A0 publication Critical patent/ITMI910381A0/en
Publication of ITMI910381A1 publication Critical patent/ITMI910381A1/en
Application granted granted Critical
Publication of IT1244743B publication Critical patent/IT1244743B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Abstract

La presente invenzione concerne l'utilizzazione di un lisato batterico sotto forma concentrato e liofilizzato proveniente da uno dei seguenti ceppi: Haemophilus influenzae (serotipe b), Diplococcus pneumoniae (serotipi 1, 2, 3, 47), Klebsiella pneumoniae, Klebsiella ozaenac, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes (serogroupe A), Branhamella catarrhalis (anc. Neisseria catarrhalis), per la fabbricazione di un medicamento destinato al trattamento della dermatite atopica.The present invention relates to the use of a concentrated and lyophilized bacterial lysate from one of the following strains: Haemophilus influenzae (serotipe b), Diplococcus pneumoniae (serotypes 1, 2, 3, 47), Klebsiella pneumoniae, Klebsiella ozaenac, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes (serogroupe A), Branhamella catarrhalis (anc. Neisseria catarrhalis), for the manufacture of a medicament intended for the treatment of atopic dermatitis.

ITMI910381A 1990-02-16 1991-02-14 MEDICATION FOR THE TREATMENT OF DERMATITIS IT1244743B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH497/90A CH680045A5 (en) 1990-02-16 1990-02-16

Publications (3)

Publication Number Publication Date
ITMI910381A0 ITMI910381A0 (en) 1991-02-14
ITMI910381A1 ITMI910381A1 (en) 1992-08-14
IT1244743B true IT1244743B (en) 1994-08-08

Family

ID=4188357

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910381A IT1244743B (en) 1990-02-16 1991-02-14 MEDICATION FOR THE TREATMENT OF DERMATITIS

Country Status (13)

Country Link
JP (1) JP3002552B2 (en)
KR (1) KR0169982B1 (en)
AT (1) AT402152B (en)
BE (1) BE1005589A3 (en)
CH (1) CH680045A5 (en)
DE (1) DE4104728C2 (en)
EG (1) EG19540A (en)
FR (1) FR2658419B1 (en)
GB (1) GB2240922A (en)
HU (1) HU210834B (en)
IT (1) IT1244743B (en)
PL (1) PL289084A1 (en)
PT (1) PT96789B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098109C1 (en) * 1996-09-26 1997-12-10 Александр Григорьевич Чучалин Antiallergic, antiinflammatory agent, method of its preparing, curative and cosmetic agent and its use
WO1999048510A1 (en) * 1998-03-24 1999-09-30 Tayca Corporation Immunoglobulin m antibody production inhibitor and anti-rheumatoid arthritis drug
JP2008529960A (en) 2003-06-23 2008-08-07 バイオテック トゥールス ソシエテ アノニム Epitope composition
UA72065C2 (en) * 2004-09-10 2005-01-17 Viridans Ltd Liability Company Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain
FR2969657B1 (en) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique NOVEL BACTERIA AND EXTRACTS OF SAID BACTERIUM AND THEIR USE IN DERMATOLOGY
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR102437436B1 (en) 2019-04-26 2022-08-30 주식회사 엠디헬스케어 Proteins derived from Streptococcus pyogenes bacteria and Use thereof
WO2020218868A1 (en) * 2019-04-26 2020-10-29 주식회사 엠디헬스케어 Streptococcus pyogenes bacteria-derived protein, and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (en) * 1978-05-26 1982-11-30 Om Laboratoires Sa MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.

Also Published As

Publication number Publication date
FR2658419A1 (en) 1991-08-23
PL289084A1 (en) 1991-11-04
KR910015306A (en) 1991-09-30
PT96789A (en) 1991-10-31
GB2240922A (en) 1991-08-21
EG19540A (en) 1995-08-30
HUT61201A (en) 1992-12-28
AT402152B (en) 1997-02-25
ITMI910381A1 (en) 1992-08-14
DE4104728C2 (en) 1999-01-14
BE1005589A3 (en) 1993-11-16
GB9103278D0 (en) 1991-04-03
HU210834B (en) 1995-08-28
DE4104728A1 (en) 1991-08-22
KR0169982B1 (en) 1999-02-01
JPH04211017A (en) 1992-08-03
ITMI910381A0 (en) 1991-02-14
FR2658419B1 (en) 1995-01-27
PT96789B (en) 1998-08-31
HU910511D0 (en) 1991-09-30
CH680045A5 (en) 1992-06-15
JP3002552B2 (en) 2000-01-24
ATA32291A (en) 1996-07-15

Similar Documents

Publication Publication Date Title
DE69527195T2 (en) ANTI GRAM POSITIVE BACTERIAL PROCESS AND MEANS
EP0665754A4 (en) Antimicrobial peptides.
IT1244743B (en) MEDICATION FOR THE TREATMENT OF DERMATITIS
Gill et al. Changing patterns of bacterial resistance to antimicrobial drugs
Phillips et al. In-vitro comparison of erythromycin, lincomycin, and clindamycin
Hui et al. Prospective study of the aetiology of adult community acquired bacterial pneumonia needing hospitalisation in Singapore
Segev et al. Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections
AU7792294A (en) Antibacterial composition containing multimeric alpha-lactalbumin
Ginsburg Streptococcus.
FR2426470A1 (en) IMMUNOBIOTHERAPIC DRUG AGAINST INFECTIOUS DISEASES OF THE RESPIRATORY TRACT
Bernard et al. In Vivo Selection of Streptococcus pneumoniae, Resistant to Quinolones, Including Sparfloxin
Uezumi et al. Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection
Calandra Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients.
Perkins et al. Cephaloglycin: crossover absorption studies and clinical evaluation
Anzueto et al. Safety and efficacy of clarithromycin vs cefuroxime axetil in the treatment of acute bacterial exacerbation of chronic bronchitis.
Ling et al. Antimicrobial resistance of clinical isolates from 1987 to 1993 in Hong Kong
Neu New strategies for the 1990's: antibacterial therapy
Özçelik et al. Sputum bacteriology and its antibiotic susceptibilities in Turkish cystic fibrosis patients
JP2004507440A5 (en)
ES8707251A1 (en) Antibiotics, their production and use.
Sato et al. Antibacterial activity of cefpirome against clinically isolated strains in pediatric patients
Farhadi et al. Bacterial etiologies and antibiotic resistance in sinusitis: A study of 264 cases.
Ryabichenko et al. Inhibition of bactericidal activity of mouse peritoneal macrophages under combined use of staphylococcal enterotoxin type A and endotoxin.
Feder Jr et al. Group A streptococcal multifocal septic arthritis: a case report
Simonet et al. Cefapirin activity against bacterial strains isolated from childrens acute otitis media.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960209